Nyxoah S A (NYXH)

$5.87 -0.05 (-0.84%)
Market Cap 199.93M
Revenue (ttm) 4.89M
Net Income (ttm) -64.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,310.84%
Debt to Equity Ratio 0.17
Volume 48,700
Avg Vol 151,540
Day's Range N/A - N/A
Shares Out 34.06M
Stochastic %K 33%
Beta 1.55
Analysts Strong Sell
Price Target $13.83

Latest News on NYXH

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 22, 2025, 10:00 AM EDT - 5 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 21, 2025, 10:00 AM EDT - 6 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 7 days ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 18, 2025, 10:00 AM EDT - 9 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 17, 2025, 10:00 AM EDT - 10 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 10:00 AM EDT - 11 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Conditional Issuance of Shares

Apr 16, 2025, 2:00 AM EDT - 11 days ago

Conditional Issuance of Shares

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 12 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 13 days ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 11, 2025, 10:00 AM EDT - 16 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 17 days ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 18 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 10:00 AM EDT - 19 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 8, 2025, 1:00 AM EDT - 19 days ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

Apr 7, 2025, 3:00 PM EDT - 19 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 20 days ago

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Mar 31, 2025, 5:40 PM EDT - 26 days ago

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

Mar 31, 2025, 2:45 PM EDT - 26 days ago

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Mar 26, 2025, 3:00 AM EDT - 4 weeks ago

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 4:45 PM EDT - 6 weeks ago

Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Mar 13, 2025, 2:00 AM EDT - 6 weeks ago

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Mar 10, 2025, 5:05 PM EDT - 6 weeks ago

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 3, 2025, 4:30 PM EST - 7 weeks ago

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Feb 19, 2025, 1:05 AM EST - 2 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Publication relating to transparency notifications

Jan 20, 2025, 4:30 PM EST - 3 months ago

Publication relating to transparency notifications

Nyxoah: The Future Of OSA

Dec 30, 2024, 4:01 AM EST - 4 months ago

Nyxoah: The Future Of OSA

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Dec 13, 2024, 2:05 AM EST - 4 months ago

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 5 months ago

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nov 19, 2024, 1:00 AM EST - 5 months ago

Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024

Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 6:46 PM EST - 6 months ago

Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript

Nyxoah Appoints John Landry as Chief Financial Officer

Nov 4, 2024, 4:45 PM EST - 6 months ago

Nyxoah Appoints John Landry as Chief Financial Officer

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Oct 22, 2024, 4:30 PM EDT - 6 months ago

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Nyxoah Raises $27 Million through its At-the-Market Offering

Oct 7, 2024, 5:00 PM EDT - 7 months ago

Nyxoah Raises $27 Million through its At-the-Market Offering

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Sep 27, 2024, 4:30 PM EDT - 7 months ago

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update

Nyxoah to Participate in Upcoming Investor Conferences

Sep 5, 2024, 4:30 PM EDT - 8 months ago

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Sep 2, 2024, 4:05 PM EDT - 8 months ago

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 1:44 AM EDT - 9 months ago

Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

Aug 6, 2024, 4:05 PM EDT - 9 months ago

Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results

Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024

Jul 29, 2024, 4:30 PM EDT - 9 months ago

Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Jul 15, 2024, 2:00 AM EDT - 10 months ago

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Jul 3, 2024, 6:30 AM EDT - 10 months ago

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Jul 1, 2024, 2:00 AM EDT - 10 months ago

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah to Participate in the Jefferies Global Healthcare Conference

Jun 3, 2024, 4:30 PM EDT - 11 months ago

Nyxoah to Participate in the Jefferies Global Healthcare Conference

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

May 31, 2024, 2:00 AM EDT - 11 months ago

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

Nyxoah Announces Pricing of Offering

May 23, 2024, 9:59 AM EDT - 1 year ago

Nyxoah Announces Pricing of Offering

Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program

May 22, 2024, 4:10 PM EDT - 1 year ago

Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program

Nyxoah Announces Proposed Offering of Ordinary Shares

May 22, 2024, 4:05 PM EDT - 1 year ago

Nyxoah Announces Proposed Offering of Ordinary Shares